Clinical Trials Browser

Solid Tumor, Adult × pembrolizumab × 30 days × Clear all

NCT06462794 2026-05-15

First In Human Study of CX-801 in Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor, Adult